Related references
Note: Only part of the references are listed.GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses
Firas Hamdan et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy
Siri Tahtinen et al.
CANCER RESEARCH (2020)
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
Jenna H. Newman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy
Pamela C. Rosato et al.
NATURE COMMUNICATIONS (2019)
Immunotherapies: Exploiting the Immune System for Cancer Treatment
Jeffrey Koury et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni et al.
NATURE (2018)
Molecular mimicry and autoimmunity
Manuel Rojas et al.
JOURNAL OF AUTOIMMUNITY (2018)
T cell receptor fingerprinting enables in-death characterization of the interactions governing recognition of peptide-MHC complexes
Amalie K. Bentzen et al.
NATURE BIOTECHNOLOGY (2018)
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017
Selma Ugurel et al.
EUROPEAN JOURNAL OF CANCER (2017)
Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis
Cindy Franklin et al.
EUROPEAN JOURNAL OF CANCER (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
The problem with neoantigen prediction
NATURE BIOTECHNOLOGY (2017)
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
D. P. Carbone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity
Dan A. Erkes et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas et al.
CELL (2017)
Gapped sequence alignment using artificial neural networks: application to the MHC class I system
Massimo Andreatta et al.
BIOINFORMATICS (2016)
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma
Cristian Capasso et al.
ONCOIMMUNOLOGY (2016)
Identification of human viral protein-derived ligands recognized by individual MHCI-restricted T-cell receptors
Barbara Szomolay et al.
IMMUNOLOGY AND CELL BIOLOGY (2016)
Preclinical and clinical development of DNA vaccines for prostate cancer
V. T. Colluru et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
DockTope: a Web-based tool for automated pMHC-I modelling
Mauricio Menegatti Rigo et al.
SCIENTIFIC REPORTS (2015)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
A Single Autoimmune T Cell Receptor Recognizes More Than a Million Different Peptides
Linda Wooldridge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor Clearance
Vincenzo Cerullo et al.
MOLECULAR THERAPY (2012)
INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies
B. Ying et al.
CANCER GENE THERAPY (2009)
Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma
Jedd D. Wolchok et al.
MOLECULAR THERAPY (2007)
Adenoviruses as vaccine vectors
N Tatsis et al.
MOLECULAR THERAPY (2004)
Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy
G Halldén et al.
MOLECULAR THERAPY (2003)
A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen
JS Gold et al.
JOURNAL OF IMMUNOLOGY (2003)
Class I major histocompatibility complex anchor substitutions alter the conformation of T cell receptor contacts
AK Sharma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
